Genetically Engineered Ascorbic acid-deficient Live Mutants of Leishmania donovani induce long lasting Protective Immunity against Visceral Leishmaniasis.
about
Possibilities and challenges for developing a successful vaccine for leishmaniasisMicroRNA expression profiling of Leishmania donovani-infected host cells uncovers the regulatory role of MIR30A-3p in host autophagy.Delivery systems for Leishmania vaccine development.Whole genome sequencing of live attenuated Leishmania donovani parasites reveals novel biomarkers of attenuation and enables product characterization.Alternative to Chemotherapy-The Unmet Demand against Leishmaniasis.Growth arrested live-attenuated Leishmania infantum KHARON1 null mutants display cytokinesis defect and protective immunity in mice
P2860
Genetically Engineered Ascorbic acid-deficient Live Mutants of Leishmania donovani induce long lasting Protective Immunity against Visceral Leishmaniasis.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Genetically Engineered Ascorbi ...... gainst Visceral Leishmaniasis.
@ast
Genetically Engineered Ascorbi ...... gainst Visceral Leishmaniasis.
@en
type
label
Genetically Engineered Ascorbi ...... gainst Visceral Leishmaniasis.
@ast
Genetically Engineered Ascorbi ...... gainst Visceral Leishmaniasis.
@en
prefLabel
Genetically Engineered Ascorbi ...... gainst Visceral Leishmaniasis.
@ast
Genetically Engineered Ascorbi ...... gainst Visceral Leishmaniasis.
@en
P2860
P356
P1433
P1476
Genetically Engineered Ascorbi ...... against Visceral Leishmaniasis
@en
P2093
Sneha Anand
P2860
P2888
P356
10.1038/SREP10706
P407
P577
2015-06-02T00:00:00Z